Patent details

EP3463458 Title: COMBINED USE OF MARIZOMIB AND BEVACIZUMAB FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM (CNS) CANCERS

Basic Information

Publication number:
EP3463458
PCT Application Number:
US2017035504
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP177306289
PCT Publication Number:
WO2017210463
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINED USE OF MARIZOMIB AND BEVACIZUMAB FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM (CNS) CANCERS
French Title of Invention:
UTILISATION COMBINÉE DE MARIZOMIB ET BEVACIZUMAB POUR LE TRAITEMENT DES CANCERS DU SYSTÈME NERVEUX CENTRAL (SNC)
German Title of Invention:
KOMBINIERTE VERWENDUNG VON MARIZOMIB UND BEVACIZUMAB ZUR BEHANDLUNG VON KREBS DES ZENTRALEN NERVENSYSTEMS (ZNS)
SPC Number:

Dates

Filing date:
01/06/2017
Grant date:
10/04/2024
EP Publication Date:
10/04/2019
PCT Publication Date:
07/12/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
10/04/2024
EP B1 Publication Date:
10/04/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
01/06/2024
Expiration date:
01/06/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
03/04/2024
 
 

Name:
Celgene Tri A Holdings Ltd.
Address:
Aon House 30 Woodbourne Avenue, Pembroke HM 08, Bermuda (BM)

Name:
Levin, Nancy
Address:
3366 N. Torrey Pines Court 210, La Jolla, California 92037, United States (US)

Name:
Maclaren, Ann
Address:
3366 N. Torrey Pines Court 210, La Jolla, California 92037, United States (US)

Name:
Trikha, Mohit
Address:
3366 N. Torrey Pines Court 210, La Jolla, California 92037, United States (US)

Inventor

1

Name:
LEVIN, Nancy
Address:
United States (US)

2

Name:
MACLAREN, Ann
Address:
United States (US)

3

Name:
TRIKHA, Mohit
Address:
United States (US)

Priority

1

Priority Number:
201662344194 P
Priority Date:
01/06/2016
Priority Country:
United States (US)

2

Priority Number:
201662349491 P
Priority Date:
13/06/2016
Priority Country:
United States (US)

3

Priority Number:
201662362845 P
Priority Date:
15/07/2016
Priority Country:
United States (US)

4

Priority Number:
201662374136 P
Priority Date:
12/08/2016
Priority Country:
United States (US)

5

Priority Number:
201662418466 P
Priority Date:
07/11/2016
Priority Country:
United States (US)

6

Priority Number:
201662424178 P
Priority Date:
18/11/2016
Priority Country:
United States (US)

7

Priority Number:
201762471321 P
Priority Date:
14/03/2017
Priority Country:
United States (US)

8

Priority Number:
201762490528 P
Priority Date:
26/04/2017
Priority Country:
United States (US)

9

Priority Number:
201762491943 P
Priority Date:
28/04/2017
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/395; A61K 31/407; A61K 31/495; A61P 35/00; A61P 35/02;

Publication

European Patent Bulletin

Issue number:
202415
Publication date:
10/04/2024
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages